<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-08-01" modified="2018-01-31" version="204">
<accession>P08195</accession>
<accession>Q13543</accession>
<name>4F2_HUMAN</name>
<protein>
<recommendedName>
<fullName>4F2 cell-surface antigen heavy chain</fullName>
<shortName>4F2hc</shortName>
</recommendedName>
<alternativeName>
<fullName>4F2 heavy chain antigen</fullName>
</alternativeName>
<alternativeName>
<fullName>Lymphocyte activation antigen 4F2 large subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>Solute carrier family 3 member 2</fullName>
</alternativeName>
<cdAntigenName>CD98</cdAntigenName>
</protein>
<gene>
<name type="primary">SLC3A2</name>
<name type="synonym">MDU1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="6526" last="6530">
<title>Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.</title>
<authorList>
<person name="Quackenbush E."/>
<person name="Clabby M."/>
<person name="Gottesdiener K.M."/>
<person name="Barbosa J."/>
<person name="Jones N.H."/>
<person name="Strominger J.L."/>
<person name="Speck S."/>
<person name="Leiden J.M."/>
</authorList>
<dbReference type="PubMed" id="3476959"/>
<dbReference type="DOI" id="10.1073/pnas.84.18.6526"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="8618" last="8618">
<authorList>
<person name="Quackenbush E."/>
<person name="Clabby M."/>
<person name="Gottesdiener K.M."/>
<person name="Barbosa J."/>
<person name="Jones N.H."/>
<person name="Strominger J.L."/>
<person name="Speck S."/>
<person name="Leiden J.M."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="9574" last="9580">
<title>Primary structure of the human 4F2 antigen heavy chain predicts a transmembrane protein with a cytoplasmic NH2 terminus.</title>
<authorList>
<person name="Teixeira S."/>
<person name="di Grandi S."/>
<person name="Kuehn L.C."/>
</authorList>
<dbReference type="PubMed" id="3036867"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="9204" last="9208">
<title>Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2.</title>
<authorList>
<person name="Lumadue J.A."/>
<person name="Glick A.B."/>
<person name="Ruddle F.H."/>
</authorList>
<dbReference type="PubMed" id="3480538"/>
<dbReference type="DOI" id="10.1073/pnas.84.24.9204"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1988" name="Mol. Cell. Biol." volume="8" first="3809" last="3819">
<title>Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation.</title>
<authorList>
<person name="Gottesdiener K.M."/>
<person name="Karpinski B.A."/>
<person name="Lindsten T."/>
<person name="Strominger J.L."/>
<person name="Jones N.H."/>
<person name="Thompson C.B."/>
<person name="Leiden J.M."/>
</authorList>
<dbReference type="PubMed" id="3265470"/>
<dbReference type="DOI" id="10.1128/MCB.8.9.3809"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Biochim. Biophys. Acta" volume="1514" first="291" last="302">
<title>Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.</title>
<authorList>
<person name="Yanagida O."/>
<person name="Kanai Y."/>
<person name="Chairoungdua A."/>
<person name="Kim D.K."/>
<person name="Segawa H."/>
<person name="Nii T."/>
<person name="Cha S.H."/>
<person name="Matsuo H."/>
<person name="Fukushima J."/>
<person name="Fukasawa Y."/>
<person name="Tani Y."/>
<person name="Taketani Y."/>
<person name="Uchino H."/>
<person name="Kim J.Y."/>
<person name="Inatomi J."/>
<person name="Okayasu I."/>
<person name="Miyamoto K."/>
<person name="Takeda E."/>
<person name="Goya T."/>
<person name="Endou H."/>
</authorList>
<dbReference type="PubMed" id="11557028"/>
<dbReference type="DOI" id="10.1016/S0005-2736(01)00384-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 4)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3)</scope>
<source>
<tissue>Lung</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2009-10" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lao L."/>
<person name="Ryan K.L."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 1-17; 146-171; 227-245; 304-313; 440-451; 511-525 AND 593-630</scope>
<scope>ACETYLATION AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="2000-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Strausberg R.L."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 83-209 (ISOFORM 4)</scope>
<source>
<tissue>Lung carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2005-03" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 112-122; 148-160; 227-245; 248-255; 288-298; 304-313; 440-451; 511-524 AND 593-625</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>B-cell lymphoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="32437" last="32445">
<title>Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.</title>
<authorList>
<person name="Torrents D."/>
<person name="Estevez R."/>
<person name="Pineda M."/>
<person name="Fernandez E."/>
<person name="Lloberas J."/>
<person name="Shi Y.-B."/>
<person name="Zorzano A."/>
<person name="Palacin M."/>
</authorList>
<dbReference type="PubMed" id="9829974"/>
<dbReference type="DOI" id="10.1074/jbc.273.49.32437"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INHIBITION</scope>
<scope>MUTAGENESIS OF CYS-210 AND CYS-431</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="Nature" volume="395" first="288" last="291">
<title>Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.</title>
<authorList>
<person name="Mastroberardino L."/>
<person name="Spindler B."/>
<person name="Pfeiffer R."/>
<person name="Skelly P.J."/>
<person name="Loffing J."/>
<person name="Shoemaker C.B."/>
<person name="Verrey F."/>
</authorList>
<dbReference type="PubMed" id="9751058"/>
<dbReference type="DOI" id="10.1038/26246"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="49" last="57">
<title>Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family.</title>
<authorList>
<person name="Pfeiffer R."/>
<person name="Rossier G."/>
<person name="Spindler B."/>
<person name="Meier C."/>
<person name="Kuehn L.C."/>
<person name="Verrey F."/>
</authorList>
<dbReference type="PubMed" id="9878049"/>
<dbReference type="DOI" id="10.1093/emboj/18.1.49"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Biochem. J." volume="349" first="787" last="795">
<title>The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine.</title>
<authorList>
<person name="Broeer A."/>
<person name="Wagner C.A."/>
<person name="Lang F."/>
<person name="Broeer S."/>
</authorList>
<dbReference type="PubMed" id="10903140"/>
<dbReference type="DOI" id="10.1042/bj3490787"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="Biochem. J." volume="355" first="725" last="731">
<title>Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.</title>
<authorList>
<person name="Broeer A."/>
<person name="Friedrich B."/>
<person name="Wagner C.A."/>
<person name="Fillon S."/>
<person name="Ganapathy V."/>
<person name="Lang F."/>
<person name="Broeer S."/>
</authorList>
<dbReference type="PubMed" id="11311135"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="Biochem. J." volume="356" first="719" last="725">
<title>Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta.</title>
<authorList>
<person name="Ritchie J.W.A."/>
<person name="Taylor P.M."/>
</authorList>
<dbReference type="PubMed" id="11389679"/>
<dbReference type="DOI" id="10.1042/0264-6021:3560719"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="BMC Biochem." volume="2" first="10" last="10">
<title>Beta1 integrins show specific association with CD98 protein in low density membranes.</title>
<authorList>
<person name="Kolesnikova T.V."/>
<person name="Mannion B.A."/>
<person name="Berditchevski F."/>
<person name="Hemler M.E."/>
</authorList>
<dbReference type="PubMed" id="11696247"/>
<dbReference type="DOI" id="10.1186/1472-2091-2-10"/>
</citation>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH BETA-1 INTEGRINS</scope>
<scope>MUTAGENESIS OF CYS-210 AND CYS-431</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Endocrinology" volume="142" first="4339" last="4348">
<title>Thyroid hormone transport by the heterodimeric human system L amino acid transporter.</title>
<authorList>
<person name="Friesema E.C.H."/>
<person name="Docter R."/>
<person name="Moerings E.P.C.M."/>
<person name="Verrey F."/>
<person name="Krenning E.P."/>
<person name="Hennemann G."/>
<person name="Visser T.J."/>
</authorList>
<dbReference type="PubMed" id="11564694"/>
<dbReference type="DOI" id="10.1210/endo.142.10.8418"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Am. J. Physiol." volume="282" first="C196" last="C204">
<title>Expression and regulation of 4F2hc and hLAT1 in human trophoblasts.</title>
<authorList>
<person name="Okamoto Y."/>
<person name="Sakata M."/>
<person name="Ogura K."/>
<person name="Yamamoto T."/>
<person name="Yamaguchi M."/>
<person name="Tasaka K."/>
<person name="Kurachi H."/>
<person name="Tsurudome M."/>
<person name="Murata Y."/>
</authorList>
<dbReference type="PubMed" id="11742812"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="297" first="528" last="536">
<title>Molecular cloning and characterization of CT120, a novel membrane-associated gene involved in amino acid transport and glutathione metabolism.</title>
<authorList>
<person name="He X.H."/>
<person name="Di Y."/>
<person name="Li J."/>
<person name="Xie Y."/>
<person name="Tang Y."/>
<person name="Zhang F."/>
<person name="Wei L."/>
<person name="Zhang Y."/>
<person name="Qin W.X."/>
<person name="Huo K."/>
<person name="Li Y."/>
<person name="Wan D.F."/>
<person name="Gu J.R."/>
</authorList>
<dbReference type="PubMed" id="12270127"/>
<dbReference type="DOI" id="10.1016/S0006-291X(02)02227-1"/>
</citation>
<scope>INTERACTION WITH FAM57A/CT120</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Biochem. J." volume="367" first="239" last="246">
<title>Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.</title>
<authorList>
<person name="Simmons-Willis T.A."/>
<person name="Koh A.S."/>
<person name="Clarkson T.W."/>
<person name="Ballatori N."/>
</authorList>
<dbReference type="PubMed" id="12117417"/>
<dbReference type="DOI" id="10.1042/BJ20020841"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Biochim. Biophys. Acta" volume="1565" first="112" last="121">
<title>Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.</title>
<authorList>
<person name="Kim D.K."/>
<person name="Kanai Y."/>
<person name="Choi H.W."/>
<person name="Tangtrongsup S."/>
<person name="Chairoungdua A."/>
<person name="Babu E."/>
<person name="Tachampa K."/>
<person name="Anzai N."/>
<person name="Iribe Y."/>
<person name="Endou H."/>
</authorList>
<dbReference type="PubMed" id="12225859"/>
<dbReference type="DOI" id="10.1016/S0005-2736(02)00516-3"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="Proteomics" volume="2" first="212" last="223">
<title>Cluster analysis of an extensive human breast cancer cell line protein expression map database.</title>
<authorList>
<person name="Harris R.A."/>
<person name="Yang A."/>
<person name="Stein R.C."/>
<person name="Lucy K."/>
<person name="Brusten L."/>
<person name="Herath A."/>
<person name="Parekh R."/>
<person name="Waterfield M.D."/>
<person name="O'Hare M.J."/>
<person name="Neville M.A."/>
<person name="Page M.J."/>
<person name="Zvelebil M.J."/>
</authorList>
<dbReference type="PubMed" id="11840567"/>
<dbReference type="DOI" id="10.1002/1615-9861(200202)2:2&lt;212::AID-PROT212>3.0.CO;2-H"/>
</citation>
<scope>MASS SPECTROMETRY</scope>
<source>
<tissue>Mammary cancer</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="Exp. Physiol." volume="88" first="699" last="710">
<title>Nitric oxide synthesis requires activity of the cationic and neutral amino acid transport system y+L in human umbilical vein endothelium.</title>
<authorList>
<person name="Arancibia-Garavilla Y."/>
<person name="Toledo F."/>
<person name="Casanello P."/>
<person name="Sobrevia L."/>
</authorList>
<dbReference type="PubMed" id="14603368"/>
<dbReference type="DOI" id="10.1113/eph8802647"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="23672" last="23677">
<title>CD98 and intracellular adhesion molecule I regulate the activity of amino acid transporter LAT-2 in polarized intestinal epithelia.</title>
<authorList>
<person name="Liu X."/>
<person name="Charrier L."/>
<person name="Gewirtz A."/>
<person name="Sitaraman S."/>
<person name="Merlin D."/>
</authorList>
<dbReference type="PubMed" id="12716892"/>
<dbReference type="DOI" id="10.1074/jbc.M302777200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH ICAM1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="660" last="666">
<title>Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.</title>
<authorList>
<person name="Zhang H."/>
<person name="Li X.-J."/>
<person name="Martin D.B."/>
<person name="Aebersold R."/>
</authorList>
<dbReference type="PubMed" id="12754519"/>
<dbReference type="DOI" id="10.1038/nbt827"/>
</citation>
<scope>GLYCOSYLATION AT ASN-365; ASN-381 AND ASN-424</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Invest. Ophthalmol. Vis. Sci." volume="46" first="2522" last="2530">
<title>L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.</title>
<authorList>
<person name="Tomi M."/>
<person name="Mori M."/>
<person name="Tachikawa M."/>
<person name="Katayama K."/>
<person name="Terasaki T."/>
<person name="Hosoya K."/>
</authorList>
<dbReference type="PubMed" id="15980244"/>
<dbReference type="DOI" id="10.1167/iovs.04-1175"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="20102" last="20110">
<title>Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols.</title>
<authorList>
<person name="Li S."/>
<person name="Whorton A.R."/>
</authorList>
<dbReference type="PubMed" id="15769744"/>
<dbReference type="DOI" id="10.1074/jbc.M413164200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-381 AND ASN-424</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Int. J. Cancer" volume="119" first="484" last="492">
<title>L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.</title>
<authorList>
<person name="Nawashiro H."/>
<person name="Otani N."/>
<person name="Shinomiya N."/>
<person name="Fukui S."/>
<person name="Ooigawa H."/>
<person name="Shima K."/>
<person name="Matsuo H."/>
<person name="Kanai Y."/>
<person name="Endou H."/>
</authorList>
<dbReference type="PubMed" id="16496379"/>
<dbReference type="DOI" id="10.1002/ijc.21866"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="3135" last="3144">
<title>Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.</title>
<authorList>
<person name="Chi A."/>
<person name="Valencia J.C."/>
<person name="Hu Z.-Z."/>
<person name="Watabe H."/>
<person name="Yamaguchi H."/>
<person name="Mangini N.J."/>
<person name="Huang H."/>
<person name="Canfield V.A."/>
<person name="Cheng K.C."/>
<person name="Yang F."/>
<person name="Abe R."/>
<person name="Yamagishi S."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Wu C."/>
<person name="Appella E."/>
<person name="Hunt D.F."/>
</authorList>
<dbReference type="PubMed" id="17081065"/>
<dbReference type="DOI" id="10.1021/pr060363j"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E3895" last="E3895">
<title>Ecto-phosphorylation of CD98 regulates cell-cell interactions.</title>
<authorList>
<person name="Nguyen H.T.T."/>
<person name="Dalmasso G."/>
<person name="Yan Y."/>
<person name="Obertone T.S."/>
<person name="Sitaraman S.V."/>
<person name="Merlin D."/>
</authorList>
<dbReference type="PubMed" id="19065266"/>
<dbReference type="DOI" id="10.1371/journal.pone.0003895"/>
</citation>
<scope>PHOSPHORYLATION AT SER-406; SER-408; SER-410; SER-527 AND SER-531</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2 (ISOFORM 2)</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-365; ASN-381 AND ASN-506</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="913" last="923">
<title>A strategy for precise and large scale identification of core fucosylated glycoproteins.</title>
<authorList>
<person name="Jia W."/>
<person name="Lu Z."/>
<person name="Fu Y."/>
<person name="Wang H.P."/>
<person name="Wang L.H."/>
<person name="Chi H."/>
<person name="Yuan Z.F."/>
<person name="Zheng Z.B."/>
<person name="Song L.N."/>
<person name="Han H.H."/>
<person name="Liang Y.M."/>
<person name="Wang J.L."/>
<person name="Cai Y."/>
<person name="Zhang Y.K."/>
<person name="Deng Y.L."/>
<person name="Ying W.T."/>
<person name="He S.M."/>
<person name="Qian X.H."/>
</authorList>
<dbReference type="PubMed" id="19139490"/>
<dbReference type="DOI" id="10.1074/mcp.M800504-MCP200"/>
</citation>
<scope>GLYCOSYLATION AT ASN-424</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="378" last="386">
<title>Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.</title>
<authorList>
<person name="Wollscheid B."/>
<person name="Bausch-Fluck D."/>
<person name="Henderson C."/>
<person name="O'Brien R."/>
<person name="Bibel M."/>
<person name="Schiess R."/>
<person name="Aebersold R."/>
<person name="Watts J.D."/>
</authorList>
<dbReference type="PubMed" id="19349973"/>
<dbReference type="DOI" id="10.1038/nbt.1532"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-365; ASN-381; ASN-424 AND ASN-506</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2 (ISOFORM 2)</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 (ISOFORM 2)</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2 (ISOFORM 2)</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM 2)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103; SER-134 AND SER-165</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="7250" last="7250">
<title>LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.</title>
<authorList>
<person name="Milkereit R."/>
<person name="Persaud A."/>
<person name="Vanoaica L."/>
<person name="Guetg A."/>
<person name="Verrey F."/>
<person name="Rotin D."/>
</authorList>
<dbReference type="PubMed" id="25998567"/>
<dbReference type="DOI" id="10.1038/ncomms8250"/>
</citation>
<scope>INTERACTION WITH LAPTM4B</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="31444" last="31452">
<title>The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane.</title>
<authorList>
<person name="Fort J."/>
<person name="de la Ballina L.R."/>
<person name="Burghardt H.E."/>
<person name="Ferrer-Costa C."/>
<person name="Turnay J."/>
<person name="Ferrer-Orta C."/>
<person name="Uson I."/>
<person name="Zorzano A."/>
<person name="Fernandez-Recio J."/>
<person name="Orozco M."/>
<person name="Lizarbe M.A."/>
<person name="Fita I."/>
<person name="Palacin M."/>
</authorList>
<dbReference type="PubMed" id="17724034"/>
<dbReference type="DOI" id="10.1074/jbc.M704524200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 212-630</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF CYS-210</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<comment type="function">
<text evidence="13 14 15 16 17 19 21 22 24 26 27 28 36 39 40 41">Required for the function of light chain amino-acid transporters. Involved in sodium-independent, high-affinity transport of large neutral amino acids such as phenylalanine, tyrosine, leucine, arginine and tryptophan. Involved in guiding and targeting of LAT1 and LAT2 to the plasma membrane. When associated with SLC7A6 or SLC7A7 acts as an arginine/glutamine exchanger, following an antiport mechanism for amino acid transport, influencing arginine release in exchange for extracellular amino acids. Plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine. Required for normal and neoplastic cell growth. When associated with SLC7A5/LAT1, is also involved in the transport of L-DOPA across the blood-brain barrier, and that of thyroid hormones triiodothyronine (T3) and thyroxine (T4) across the cell membrane in tissues such as placenta. Involved in the uptake of methylmercury (MeHg) when administered as the L-cysteine or D,L-homocysteine complexes, and hence plays a role in metal ion homeostasis and toxicity. When associated with SLC7A5 or SLC7A8, involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L-nitrosocysteine (L-CNSO) across the transmembrane. Together with ICAM1, regulates the transport activity LAT2 in polarized intestinal cells, by generating and delivering intracellular signals. When associated with SLC7A5, plays an important role in transporting L-leucine from the circulating blood to the retina across the inner blood-retinal barrier. When associated with LAPTM4B, recruits SLC3A2 and SLC7A5 to lysosomes to promote leucine uptake into these organelles and is required for mTORC1 activation (PubMed:25998567).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="13">295 uM for glutamine (in the presence of NaCl)</KM>
<KM evidence="13">236 uM for leucine (in the presence of NaCl)</KM>
<KM evidence="13">120 uM for arginine (in the presence of NaCl)</KM>
<KM evidence="13">138 uM for arginine (in the absence of NaCl)</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="10 14 15 16 17 18 22 23 24 26 27 31 36 39 40 41">Disulfide-linked heterodimer of a glycosylated heavy chain and a non-glycosylated light chain (SLC7A5, SLC7A6, SLCA7A7, SLC7A8, SLC7A10 or SLCA7A11). Colocalizes with cadherins (By similarity). Interacts with FAM57A/CT120 and ICAM1. Constitutively and specifically associates with beta-1 integrins (alpha-2/beta-1, alpha-3/beta-1, alpha-5/beta-1 and alpha-6/beta-1), but minimally with alpha-4/beta-1. Interacts with LAPTM4B; recruits SLC3A2 and SLC7A5 to lysosomes to promote leucine uptake into these organelles and is required for mTORC1 activation (PubMed:25998567).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702356"/>
<interactant intactId="EBI-14022357">
<id>O52302</id>
<label>sepZ</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Apical cell membrane</location>
<topology>Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Melanosome</location>
</subcellularLocation>
<text evidence="10">Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Localized to the plasma membrane when associated with SLC7A5 or SLC7A8. Localized to the placental apical membrane. Located selectively at cell-cell adhesion sites (By similarity). Colocalized with SLC7A8/LAT2 at the basolateral membrane of kidney proximal tubules and small intestine epithelia. Expressed in both luminal and abluminal membranes of brain capillary endothelial cells (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P08195-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P08195-2</id>
<name>2</name>
<sequence type="described" ref="VSP_037907"/>
<text evidence="3 5 6">Initiator Met-1 is removed. Contains a N-acetylserine at position 2. Contains a phosphoserine at position 2.</text>
</isoform>
<isoform>
<id>P08195-3</id>
<name>3</name>
<sequence type="described" ref="VSP_037908"/>
</isoform>
<isoform>
<id>P08195-4</id>
<name>4</name>
<sequence type="described" ref="VSP_037909"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="15 16 19 24 26 28 30 37 38">Expressed ubiquitously in all tissues tested with highest levels detected in kidney, placenta and testis and weakest level in thymus. During gestation, expression in the placenta was significantly stronger at full-term than at the mid-trimester stage. Expressed in HUVECS and at low levels in resting peripheral blood T-lymphocytes and quiescent fibroblasts. Also expressed in fetal liver and in the astrocytic process of primary astrocytic gliomas. Expressed in retinal endothelial cells and in the intestinal epithelial cell line C2BBe1.</text>
</comment>
<comment type="induction">
<text evidence="19 37 38">Expression is induced in resting peripheral blood T-lymphocytes following PHA stimulation. Expression increases at the time of maximal DNA synthesis, in fibroblasts stimulated to divide. Expression and the uptake of leucine is stimulated in mononuclear, cytotrophoblast-like choriocarcinoma cells by combined treatment with PMA and calcium ionophore.</text>
</comment>
<comment type="PTM">
<text evidence="32">Phosphorylation on Ser-406; Ser-408 or Ser-410 and on Ser-527 or Ser-531 by ecto-protein kinases favors heterotypic cell-cell interactions.</text>
</comment>
<comment type="mass spectrometry" mass="57944.93" method="MALDI" evidence="20">
<location>
<begin position="1"/>
<end position="529"/>
</location>
</comment>
<comment type="miscellaneous">
<text>Arginine uptake is inhibited by increasing concentrations of leucine in the presence of Na(+).</text>
</comment>
<comment type="similarity">
<text evidence="49">Belongs to the SLC3A transporter family.</text>
</comment>
<dbReference type="EMBL" id="J02939">
<property type="protein sequence ID" value="AAA52497.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J02769">
<property type="protein sequence ID" value="AAA51540.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J03569">
<property type="protein sequence ID" value="AAA35536.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M21904">
<property type="protein sequence ID" value="AAA35489.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21898">
<property type="protein sequence ID" value="AAA35489.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21899">
<property type="protein sequence ID" value="AAA35489.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21900">
<property type="protein sequence ID" value="AAA35489.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21901">
<property type="protein sequence ID" value="AAA35489.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21902">
<property type="protein sequence ID" value="AAA35489.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21903">
<property type="protein sequence ID" value="AAA35489.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB018010">
<property type="protein sequence ID" value="BAA84649.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001160">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001061">
<property type="protein sequence ID" value="AAH01061.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003000">
<property type="protein sequence ID" value="AAH03000.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BE794697">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31589.1">
<molecule id="P08195-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31590.1">
<molecule id="P08195-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8039.2">
<molecule id="P08195-1"/>
</dbReference>
<dbReference type="PIR" id="A28455">
<property type="entry name" value="SAHU4F"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012680.1">
<property type="nucleotide sequence ID" value="NM_001012662.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001012682.1">
<molecule id="P08195-3"/>
<property type="nucleotide sequence ID" value="NM_001012664.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001013269.1">
<molecule id="P08195-2"/>
<property type="nucleotide sequence ID" value="NM_001013251.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002385.3">
<molecule id="P08195-1"/>
<property type="nucleotide sequence ID" value="NM_002394.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.502769"/>
<dbReference type="PDB" id="2DH2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=212-630"/>
</dbReference>
<dbReference type="PDB" id="2DH3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=212-630"/>
</dbReference>
<dbReference type="PDBsum" id="2DH2"/>
<dbReference type="PDBsum" id="2DH3"/>
<dbReference type="ProteinModelPortal" id="P08195"/>
<dbReference type="SMR" id="P08195"/>
<dbReference type="BioGrid" id="112411">
<property type="interactions" value="80"/>
</dbReference>
<dbReference type="CORUM" id="P08195"/>
<dbReference type="IntAct" id="P08195">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="MINT" id="MINT-4999018"/>
<dbReference type="STRING" id="9606.ENSP00000367123"/>
<dbReference type="GuidetoPHARMACOLOGY" id="890"/>
<dbReference type="CAZy" id="GH13">
<property type="family name" value="Glycoside Hydrolase Family 13"/>
</dbReference>
<dbReference type="TCDB" id="8.A.9.2.2">
<property type="family name" value="the rbat transport accessory protein (rbat) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P08195"/>
<dbReference type="PhosphoSitePlus" id="P08195"/>
<dbReference type="SwissPalm" id="P08195"/>
<dbReference type="BioMuta" id="SLC3A2"/>
<dbReference type="DMDM" id="257051063"/>
<dbReference type="EPD" id="P08195"/>
<dbReference type="MaxQB" id="P08195"/>
<dbReference type="PaxDb" id="P08195"/>
<dbReference type="PeptideAtlas" id="P08195"/>
<dbReference type="PRIDE" id="P08195"/>
<dbReference type="DNASU" id="6520"/>
<dbReference type="Ensembl" id="ENST00000338663">
<molecule id="P08195-2"/>
<property type="protein sequence ID" value="ENSP00000340815"/>
<property type="gene ID" value="ENSG00000168003"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000377889">
<molecule id="P08195-3"/>
<property type="protein sequence ID" value="ENSP00000367121"/>
<property type="gene ID" value="ENSG00000168003"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000377890">
<molecule id="P08195-1"/>
<property type="protein sequence ID" value="ENSP00000367122"/>
<property type="gene ID" value="ENSG00000168003"/>
</dbReference>
<dbReference type="GeneID" id="6520"/>
<dbReference type="KEGG" id="hsa:6520"/>
<dbReference type="UCSC" id="uc001nwd.4">
<molecule id="P08195-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6520"/>
<dbReference type="DisGeNET" id="6520"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000168003.16"/>
<dbReference type="GeneCards" id="SLC3A2"/>
<dbReference type="HGNC" id="HGNC:11026">
<property type="gene designation" value="SLC3A2"/>
</dbReference>
<dbReference type="HPA" id="CAB010455"/>
<dbReference type="HPA" id="HPA017980"/>
<dbReference type="MIM" id="158070">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P08195"/>
<dbReference type="OpenTargets" id="ENSG00000168003"/>
<dbReference type="PharmGKB" id="PA35894"/>
<dbReference type="eggNOG" id="KOG0471">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0366">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140965"/>
<dbReference type="HOGENOM" id="HOG000233529"/>
<dbReference type="HOVERGEN" id="HBG000023"/>
<dbReference type="InParanoid" id="P08195"/>
<dbReference type="KO" id="K06519"/>
<dbReference type="PhylomeDB" id="P08195"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000168003-MONOMER"/>
<dbReference type="Reactome" id="R-HSA-210991">
<property type="pathway name" value="Basigin interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-352230">
<property type="pathway name" value="Amino acid transport across the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-71240">
<property type="pathway name" value="Tryptophan catabolism"/>
</dbReference>
<dbReference type="SABIO-RK" id="P08195"/>
<dbReference type="ChiTaRS" id="SLC3A2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P08195"/>
<dbReference type="GeneWiki" id="SLC3A2"/>
<dbReference type="GenomeRNAi" id="6520"/>
<dbReference type="PRO" id="PR:P08195"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000168003"/>
<dbReference type="CleanEx" id="HS_SLC3A2"/>
<dbReference type="ExpressionAtlas" id="P08195">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P08195">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042470">
<property type="term" value="C:melanosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005432">
<property type="term" value="F:calcium:sodium antiporter activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003824">
<property type="term" value="F:catalytic activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0003725">
<property type="term" value="F:double-stranded RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0015175">
<property type="term" value="F:neutral amino acid transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006865">
<property type="term" value="P:amino acid transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006816">
<property type="term" value="P:calcium ion transport"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005975">
<property type="term" value="P:carbohydrate metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0016049">
<property type="term" value="P:cell growth"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902475">
<property type="term" value="P:L-alpha-amino acid transmembrane transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060356">
<property type="term" value="P:leucine import"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043330">
<property type="term" value="P:response to exogenous dsRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0015827">
<property type="term" value="P:tryptophan transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR006047">
<property type="entry name" value="Glyco_hydro_13_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017853">
<property type="entry name" value="Glycoside_hydrolase_SF"/>
</dbReference>
<dbReference type="InterPro" id="IPR031984">
<property type="entry name" value="SLC3A2_N"/>
</dbReference>
<dbReference type="Pfam" id="PF00128">
<property type="entry name" value="Alpha-amylase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16028">
<property type="entry name" value="SLC3A2_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00642">
<property type="entry name" value="Aamy"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51445">
<property type="entry name" value="SSF51445"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0029">Amino-acid transport</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="4F2 cell-surface antigen heavy chain" id="PRO_0000064383">
<location>
<begin position="1"/>
<end position="630"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="12">
<location>
<begin position="102"/>
<end position="184"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="12">
<location>
<begin position="185"/>
<end position="205"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="12">
<location>
<begin position="206"/>
<end position="630"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="7 42">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="103"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="106"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="134"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 8">
<location>
<position position="165"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="50">
<location>
<position position="406"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="50">
<location>
<position position="408"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="50">
<location>
<position position="410"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="50">
<location>
<position position="527"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="50">
<location>
<position position="531"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25 34 35">
<location>
<position position="365"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25 29 34 35">
<location>
<position position="381"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="25 29 33 35">
<location>
<position position="424"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="34 35">
<location>
<position position="506"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (with light chain)" evidence="31">
<location>
<position position="210"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)">
<location>
<position position="147"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="166"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_037907" evidence="43 45 46 47">
<location>
<begin position="1"/>
<end position="101"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_037908" evidence="44">
<location>
<begin position="38"/>
<end position="99"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_037909" evidence="48">
<original>V</original>
<variation>VTETGFHHVSQADIEFLTSIDPTASASGSAGI</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dimerization, leucine uptake and interaction with beta-1 integrins." evidence="18 31 40">
<original>C</original>
<variation>S</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on dimerization, leucine uptake or interaction with beta-1 integrins." evidence="18 40">
<original>C</original>
<variation>S</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>G</original>
<variation>E</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA51540." ref="3" evidence="49">
<original>A</original>
<variation>P</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>A</original>
<variation>P</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>E</original>
<variation>D</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA35489." ref="5" evidence="49">
<original>S</original>
<variation>F</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>E</original>
<variation>G</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>GE</original>
<variation>PQ</variation>
<location>
<begin position="412"/>
<end position="413"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>V</original>
<variation>L</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>G</original>
<variation>P</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA35489." ref="5" evidence="49">
<original>G</original>
<variation>E</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>L</original>
<variation>P</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA35536." ref="4" evidence="49">
<original>E</original>
<variation>G</variation>
<location>
<position position="612"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="218"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="224"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="230"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="241"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="248"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="257"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="275"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="287"/>
<end position="299"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="303"/>
<end position="307"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="310"/>
<end position="313"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="314"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="319"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="323"/>
<end position="340"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="344"/>
<end position="347"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="350"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="356"/>
<end position="370"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="375"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="385"/>
<end position="391"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="392"/>
<end position="394"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="399"/>
<end position="401"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="404"/>
<end position="407"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="412"/>
<end position="426"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="437"/>
<end position="439"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="441"/>
<end position="443"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="447"/>
<end position="449"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="450"/>
<end position="457"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="460"/>
<end position="467"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="470"/>
<end position="472"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="476"/>
<end position="478"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="479"/>
<end position="481"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="484"/>
<end position="486"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="493"/>
<end position="495"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="500"/>
<end position="502"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="505"/>
<end position="507"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="509"/>
<end position="513"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="519"/>
<end position="532"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="534"/>
<end position="538"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="540"/>
<end position="545"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="550"/>
<end position="556"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="562"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="570"/>
<end position="572"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="581"/>
<end position="583"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="585"/>
<end position="587"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="591"/>
<end position="603"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="607"/>
<end position="610"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="611"/>
<end position="613"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="621"/>
<end position="626"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DH2"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DH3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q794F9"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10903140"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11311135"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389679"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11557028"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11564694"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11696247"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11742812"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11840567"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12117417"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12225859"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12270127"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12716892"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12754519"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14603368"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15769744"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15980244"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16496379"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17724034"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19065266"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19139490"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349973"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25998567"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3265470"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3480538"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9751058"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9829974"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9878049"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11557028"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3036867"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3476959"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3480538"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000303">
<source ref="10"/>
</evidence>
<evidence key="49" type="ECO:0000305"/>
<evidence key="50" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19065266"/>
</source>
</evidence>
<sequence length="630" mass="67994" checksum="AE427F8204CC10B0" modified="2009-09-01" version="3">
MELQPPEASIAVVSIPRQLPGSHSEAGVQGLSAGDDSELGSHCVAQTGLELLASGDPLPS
ASQNAEMIETGSDCVTQAGLQLLASSDPPALASKNAEVTGTMSQDTEVDMKEVELNELEP
EKQPMNAASGAAMSLAGAEKNGLVKIKVAEDEAEAAAAAKFTGLSKEELLKVAGSPGWVR
TRWALLLLFWLGWLGMLAGAVVIIVRAPRCRELPAQKWWHTGALYRIGDLQAFQGHGAGN
LAGLKGRLDYLSSLKVKGLVLGPIHKNQKDDVAQTDLLQIDPNFGSKEDFDSLLQSAKKK
SIRVILDLTPNYRGENSWFSTQVDTVATKVKDALEFWLQAGVDGFQVRDIENLKDASSFL
AEWQNITKGFSEDRLLIAGTNSSDLQQILSLLESNKDLLLTSSYLSDSGSTGEHTKSLVT
QYLNATGNRWCSWSLSQARLLTSFLPAQLLRLYQLMLFTLPGTPVFSYGDEIGLDAAALP
GQPMEAPVMLWDESSFPDIPGAVSANMTVKGQSEDPGSLLSLFRRLSDQRSKERSLLHGD
FHAFSAGPGLFSYIRHWDQNERFLVVLNFGDVGLSAGLQASDLPASASLPAKADLLLSTQ
PGREEGSPLELERLKLEPHEGLLLRFPYAA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>